24/7 Market News Snapshot 25 September, 2025 – N2OFF, Inc. Common Stock (NASDAQ:NITO)

September 25, 2025

DENVER, Colo., 25 September, 2025 (www.247marketnews.com) – (NASDAQ:NITO) are discussed in this article.
N2OFF, Inc. (NASDAQ:NITO) is currently experiencing a remarkable surge in its stock price, reflecting strong investor enthusiasm and confidence. The stock, which opened at $5.16, has soared to $9.72, marking an impressive increase of 79.37% from its previous close of $5.42. With a trading volume of 2.69 million shares, the heightened market activity indicates robust interest from the investment community. Analysts suggest that this upward momentum may be indicative of NITO’s potential as a significant player in the market.

Adding to this excitement, N2OFF has announced the successful completion of a stockholder vote regarding its strategic acquisition of MitoCareX Bio Ltd., a cutting-edge biotechnology firm specializing in drug discovery for cancer therapies. The vote, which took place on September 25, 2025, represents a critical step forward in N2OFF’s growth strategy.

MitoCareX is known for its innovative approach to developing therapies targeting the mitochondrial SLC25 protein family, focusing on hard-to-treat cancers. Their advanced 3D comparative modeling and in-vitro screening capabilities allow for effective identification of small molecule therapeutics, positioning the company favorably within the expanding global cancer therapeutics market, projected to reach $344.1 billion by 2031.

Under the agreement, N2OFF will complete the acquisition of MitoCareX through a combination of cash and stock transactions, including an upfront investment of $700,000. N2OFF is also committed to investing an additional $1 million to support MitoCareX’s operations in the subsequent two years. This deal not only enhances N2OFF’s portfolio but also aims to drive innovation in both the cleantech and biotech sectors.

Chairman Amitay Weiss expressed optimism regarding the merger, highlighting the collaborative potential to generate long-term value and bolster the company’s impact across multiple industries. The acquisition is expected to be finalized by mid-October, pending the fulfillment of closing conditions, reinforcing N2OFF’s ambition to lead in both renewable energy and healthcare solutions.

Related news for (NITO)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.